Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).

about

Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).

Item

http://www.wikidata.org/entity/Q38759710

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).

@en

type

Item

label

Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).

@en

prefLabel

Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).

@en

P1476

Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).

@en

P2093

Christopher Chermansky

http://www.w3.org/2001/XMLSchema#string

Mahendra Kashyap

http://www.w3.org/2001/XMLSchema#string

Pradeep Tyagi

http://www.w3.org/2001/XMLSchema#string

Yao-Chi Chuang

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States

Cross-talk and sensitization of bladder afferent nerves

Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions

Sensory dysfunction of bladder mucosa and bladder oversensitivity in a rat model of metabolic syndrome

Suppression of the PI3K pathway in vivo reduces cystitis-induced bladder hypertrophy and restores bladder capacity examined by magnetic resonance imaging

Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder.

Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium.

Clinical comparision of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome/interstitital cystitis.

Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device.

Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis.

P304

521-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2016.1162290

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26940379

http://www.w3.org/2001/XMLSchema#string